These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12202660)

  • 1. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.
    Bennett CL; Price DK; Kim S; Liu D; Jovanovic BD; Nathan D; Johnson ME; Montgomery JS; Cude K; Brockbank JC; Sartor O; Figg WD
    J Clin Oncol; 2002 Sep; 20(17):3599-604. PubMed ID: 12202660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.
    Balic I; Graham ST; Troyer DA; Higgins BA; Pollock BH; Johnson-Pais TL; Thompson IM; Leach RJ
    J Urol; 2002 Nov; 168(5):2245-8. PubMed ID: 12394768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population.
    Gilligan T; Manola J; Sartor O; Weinrich SP; Moul JW; Kantoff PW
    Clin Prostate Cancer; 2004 Sep; 3(2):98-103. PubMed ID: 15479493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
    Nam RK; Elhaji Y; Krahn MD; Hakimi J; Ho M; Chu W; Sweet J; Trachtenberg J; Jewett MA; Narod SA
    J Urol; 2000 Aug; 164(2):567-72. PubMed ID: 10893645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study.
    Lange EM; Sarma AV; Ray A; Wang Y; Ho LA; Anderson SA; Cunningham JM; Cooney KA
    J Hum Genet; 2008; 53(3):220-226. PubMed ID: 18217192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer.
    Sartor O; Zheng Q; Eastham JA
    Urology; 1999 Feb; 53(2):378-80. PubMed ID: 9933058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of CAG repeats in exon 1 of the androgen receptor on disease progression after prostatectomy.
    Powell IJ; Land SJ; Dey J; Heilbrun LK; Hughes MR; Sakr W; Everson RB
    Cancer; 2005 Feb; 103(3):528-37. PubMed ID: 15630701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CAG trinucleotide repeat length in the androgen receptor does not predict the early onset of prostate cancer.
    Mir K; Edwards J; Paterson PJ; Hehir M; Underwood MA; Bartlett JM
    BJU Int; 2002 Oct; 90(6):573-8. PubMed ID: 12230620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.
    Giovannucci E; Stampfer MJ; Krithivas K; Brown M; Dahl D; Brufsky A; Talcott J; Hennekens CH; Kantoff PW
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3320-3. PubMed ID: 9096391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk.
    Gsur A; Preyer M; Haidinger G; Zidek T; Madersbacher S; Schatzl G; Marberger M; Vutuc C; Micksche M
    Carcinogenesis; 2002 Oct; 23(10):1647-51. PubMed ID: 12376473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size of the androgen receptor CAG repeat and prostate cancer: does it matter?
    Coetzee G; Irvine R
    J Clin Oncol; 2002 Sep; 20(17):3572-3. PubMed ID: 12202654
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer.
    Tan JSJ; Ong KC; Ong DBL; Wu YS; Razack A; Kuppusamy S; Lim J; Rhodes A
    Malays J Pathol; 2019 Dec; 41(3):243-251. PubMed ID: 31901908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.
    Schildkraut JM; Murphy SK; Palmieri RT; Iversen E; Moorman PG; Huang Z; Halabi S; Calingaert B; Gusberg A; Marks JR; Berchuck A
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):473-80. PubMed ID: 17372242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset.
    Hardy DO; Scher HI; Bogenreider T; Sabbatini P; Zhang ZF; Nanus DM; Catterall JF
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4400-5. PubMed ID: 8954049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
    Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
    J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.
    Platz EA; Rimm EB; Willett WC; Kantoff PW; Giovannucci E
    J Natl Cancer Inst; 2000 Dec; 92(24):2009-17. PubMed ID: 11121463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor CAG polymorphism and prostate cancer risk.
    Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
    Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.